332 related articles for article (PubMed ID: 28162092)
1. The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.
Fonseca AB; Simon MD; Cazzaniga RA; de Moura TR; de Almeida RP; Duthie MS; Reed SG; de Jesus AR
Infect Dis Poverty; 2017 Feb; 6(1):5. PubMed ID: 28162092
[TBL] [Abstract][Full Text] [Related]
2. Emerging Concepts of Adaptive Immunity in Leprosy.
Sadhu S; Mitra DK
Front Immunol; 2018; 9():604. PubMed ID: 29686668
[TBL] [Abstract][Full Text] [Related]
3. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
5. Fate of T Cells and their Secretory Proteins During the Progression of Leprosy.
Tarique M; Saini C; Naz H; Naqvi RA; Khan FI; Sharma A
Curr Protein Pept Sci; 2018; 19(9):889-899. PubMed ID: 28847289
[TBL] [Abstract][Full Text] [Related]
6. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
7. IL-37 and leprosy: A novel cytokine involved in the host response to Mycobacterium leprae infection.
de Sousa JR; Prudente RL; Dias Junior LB; Oliveira Carneiro FR; Sotto MN; Simões Quaresma JA
Cytokine; 2018 Jun; 106():89-94. PubMed ID: 29111085
[TBL] [Abstract][Full Text] [Related]
8. T helper cells in leprosy: An update.
Saini C; Tarique M; Rai R; Siddiqui A; Khanna N; Sharma A
Immunol Lett; 2017 Apr; 184():61-66. PubMed ID: 28235552
[TBL] [Abstract][Full Text] [Related]
9. A hypothetical role for Notch signaling pathway in immunopathogenesis of leprosy.
Serrano-Coll H; Acevedo-Saenz L; Cardona-Castro N
Med Hypotheses; 2017 Nov; 109():162-169. PubMed ID: 29150278
[TBL] [Abstract][Full Text] [Related]
10. Leprosy as a model of immunity.
Degang Y; Nakamura K; Akama T; Ishido Y; Luo Y; Ishii N; Suzuki K
Future Microbiol; 2014; 9(1):43-54. PubMed ID: 24328380
[TBL] [Abstract][Full Text] [Related]
11. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
12. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
13. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
14. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
15. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
18. Micronutrients influencing the immune response in leprosy.
Passos Vázquez CM; Mendes Netto RS; Ferreira Barbosa KB; Rodrigues de Moura T; de Almeida RP; Duthie MS; Ribeiro de Jesus A
Nutr Hosp; 2014 Jan; 29(1):26-36. PubMed ID: 24483959
[TBL] [Abstract][Full Text] [Related]
19. [Leprosy in Brazil].
Araújo MG
Rev Soc Bras Med Trop; 2003; 36(3):373-82. PubMed ID: 12908039
[TBL] [Abstract][Full Text] [Related]
20. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
